• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM Back to Search Results
Model Number 442963
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/23/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It has been reported that the bd max¿ enteric bacterial panel has been found producing false negative results.Cultures were used for confirmatory testing.Delayed patient treatment was reported.The following has been provided by the initial reporter: customer is investigating a suspected problem with enteric bacterial panel on the bd max and its ability to detect salmonella.In the last 4-5 weeks customer has had 3 bd max salmonella negative results that are culture positive.Two of these are s.Typhi and one was detected over a week after the initial negative result.
 
Event Description
Customer is investigating a suspected problem with enteric bacterial panel on the bd max and it has been reported that the bd max¿ enteric bacterial panel has been found producing false negative results.Cultures were used for confirmatory testing.Delayed patient treatment was reported.The following has been provided by the initial reporter: customer is investigating a suspected problem with enteric bacterial panel on the bd max and its ability to detect salmonella.In the last 4-5 weeks customer has had 3 bd max salmonella negative results that are culture positive.Two of these are s.Typhi and one was detected over a week after the initial negative result.
 
Manufacturer Narrative
H6: investigation summary: the complaint investigation for discrepant results when using the bd max¿ enteric bacterial panel assay (ref.442963) lot 1074231 was performed by the review of the manufacturing records, retain material testing and by the complaint¿s history review.Review of the manufacturing records of bd max¿ enteric bacterial panel assay indicated that the lot was manufactured according to specifications and met performance requirements.The retain material of bd max¿ enteric bacterial panel from lot 1074231 was tested in positive and all the reactions gave positive results, as expected.Customer reported three negative samples with bd max¿ enteric bacterial panel which gave a positive result for salmonella in culture.Customer stated that two of them were s.Typhi and one of them was detected one week after the initial negative result.Despite several requests made to the customer, no data or additional information was provided for the investigation.Sequence analysis revealed that salmonella typhi is detected with the bd max¿ enteric bacterial panel assay.Multiple causes could explain the customer reported discrepant results, but without data no analysis was possible.Although the exact cause for the customer issue could not be identified, based on the investigation the reagents are not suspected.The root cause was not identified.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max¿ enteric bacterial panel lot 1074231.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action (capa).Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ ENTERIC BACTERIAL PANEL
Type of Device
GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14289452
MDR Text Key299612896
Report Number3007420875-2022-00019
Device Sequence Number1
Product Code PCI
UDI-Device Identifier00382904429638
UDI-Public00382904429638
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K140111
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/10/2022
Device Model Number442963
Device Catalogue Number442963
Device Lot Number1074231
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-